{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:17:41Z","timestamp":1781878661927,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10072-025-08062-5","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T10:49:23Z","timestamp":1740826163000},"page":"2985-2994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Safety and efficacy of arimoclomol in amyotrophic lateral sclerosis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9697-524X","authenticated-orcid":false,"given":"Saad","family":"Masood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1077-7307","authenticated-orcid":false,"given":"Muhammad Sameer","family":"Almas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5777-239X","authenticated-orcid":false,"given":"Syed Saad Ul","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7565-8052","authenticated-orcid":false,"given":"Sameen","family":"Tahira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7952-6714","authenticated-orcid":false,"given":"Muhammad Hamza","family":"Fiaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8770-1763","authenticated-orcid":false,"given":"Umm E Aimen","family":"Minhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6202-1673","authenticated-orcid":false,"given":"Hafiz Muhammad Qasim","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3823-4804","authenticated-orcid":false,"given":"Musa","family":"Masood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"issue":"24\u201325","key":"8062_CR1","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1055\/a-1562-7882","volume":"146","author":"T Meyer","year":"2021","unstructured":"Meyer T (2021) [Amyotrophic lateral sclerosis (ALS) - diagnosis, course of disease and treatment options]. Dtsch Med Wochenschr [Internet] 146(24\u201325):1613\u20138. https:\/\/doi.org\/10.1055\/a-1562-7882","journal-title":"Dtsch Med Wochenschr [Internet]"},{"key":"8062_CR2","doi-asserted-by":"publisher","unstructured":"Talbott EO, Malek AM, Lacomis D (2016) The epidemiology of amyotrophic lateral sclerosis. 225\u201338. https:\/\/doi.org\/10.1016\/B978-0-12-802973-2.00013-6","DOI":"10.1016\/B978-0-12-802973-2.00013-6"},{"issue":"1","key":"8062_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41598-021-03891-8","volume":"12","author":"M Berdy\u0144ski","year":"2022","unstructured":"Berdy\u0144ski M, Miszta P, Safranow K, Andersen PM, Morita M, Filipek S et al (2022) SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity. Sci Rep [Internet] 12(1):103. https:\/\/doi.org\/10.1038\/s41598-021-03891-8","journal-title":"Sci Rep [Internet]"},{"key":"8062_CR4","unstructured":"FDA-approved drugs for treating ALS [Internet]. [cited 2024 Jul 26]. Available from: https:\/\/www.als.org\/navigating-als\/living-with-als\/fda-approved-drugs"},{"issue":"11","key":"8062_CR5","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/d41573-024-00162-9","volume":"23","author":"A Mullard","year":"2024","unstructured":"Mullard A (2024) FDA approves first two drugs for rare Niemann-Pick disease. Nat Rev Drug Discov 23(11):804\u2013804","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"8062_CR6","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1517\/13543780903357486","volume":"18","author":"V Lanka","year":"2009","unstructured":"Lanka V, Wieland S, Barber J, Cudkowicz M (2009) Arimoclomol: a potential therapy under development for ALS. Expert Opin Investig Drugs [Internet] 18(12):1907\u201318. https:\/\/doi.org\/10.1517\/13543780903357486","journal-title":"Expert Opin Investig Drugs [Internet]"},{"issue":"1","key":"8062_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pharmthera.2013.08.003","volume":"141","author":"B Kalmar","year":"2013","unstructured":"Kalmar B, Lu CH, Greensmith L (2013) The role of heat shock proteins in Amyotrophic Lateral Sclerosis: the therapeutic potential of Arimoclomol. Pharmacol Ther [Internet] 141(1):40\u201354. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.08.003","journal-title":"Pharmacol Ther [Internet]"},{"key":"8062_CR8","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 29:n71","journal-title":"BMJ"},{"issue":"1","key":"8062_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5(1):210","journal-title":"Syst Rev"},{"key":"8062_CR10","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 28:l4898","journal-title":"BMJ"},{"key":"8062_CR11","unstructured":"Review manager (RevMan) [Computer program]. Version 5.4. The cochrane collaboration, 2020"},{"issue":"4","key":"8062_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nm1021","volume":"10","author":"D Kieran","year":"2004","unstructured":"Kieran D, Kalmar B, Dick JRT, Riddoch-Contreras J, Burnstock G, Greensmith L (2004) Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat Med 10(4):402\u2013405","journal-title":"Nat Med"},{"issue":"2","key":"8062_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1471-4159.2008.05595.x","volume":"107","author":"B Kalmar","year":"2008","unstructured":"Kalmar B, Novoselov S, Gray A, Cheetham ME, Margulis B, Greensmith L (2008) Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1 G93A mouse model of ALS. J Neurochem 107(2):339\u2013350","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"8062_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","volume":"169","author":"JM Cedarbaum","year":"1999","unstructured":"Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169(1\u20132):13\u201321","journal-title":"J Neurol Sci"},{"issue":"1","key":"8062_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ana.20903","volume":"60","author":"ME Cudkowicz","year":"2006","unstructured":"Cudkowicz ME, Shefner JM, Schoenfeld DA, Zhang H, Andreasson KI, Rothstein JD et al (2006) Trial of celecoxib in amyotrophic lateral sclerosis. Ann Neurol 60(1):22\u201331","journal-title":"Ann Neurol"},{"key":"8062_CR16","first-page":"14","volume":"25","author":"E Elliott","year":"2020","unstructured":"Elliott E, Bailey O, Waldron FM, Hardingham GE, Chandran S, Gregory JM (2020) Therapeutic targeting of proteostasis in amyotrophic lateral sclerosis\u2014a systematic review and meta-analysis of preclinical research. Front Neurosci 25:14","journal-title":"Front Neurosci"},{"issue":"1","key":"8062_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0733-8619(18)30932-0","volume":"5","author":"SR Braun","year":"1987","unstructured":"Braun SR (1987) Respiratory system in amyotrophic lateral sclerosis. Neurol Clin 5(1):9\u201331","journal-title":"Neurol Clin"},{"issue":"4","key":"8062_CR18","doi-asserted-by":"publisher","first-page":"1900360","DOI":"10.1183\/13993003.00360-2019","volume":"53","author":"N Lechtzin","year":"2019","unstructured":"Lechtzin N (2019) Predicting respiratory failure in amyotrophic lateral sclerosis: recruiting a few good pulmonologists. Eur Respir J 53(4):1900360","journal-title":"Eur Respir J"},{"key":"8062_CR19","unstructured":"ALS symptoms: difficulty breathing and swallowing | ALS News Today [Internet]. [cited 2024 Oct 3]. Available from: https:\/\/alsnewstoday.com\/als-symptoms\/difficulty-swallowing\/. Accessed 30 Nov 2023"},{"key":"8062_CR20","unstructured":"Amyotrophic lateral sclerosis (ALS) - Symptoms and causes - Mayo Clinic [Internet]. [cited 2024 Oct 3]. Available from: https:\/\/www.mayoclinic.org\/diseases-conditions\/amyotrophic-lateral-sclerosis\/symptoms-causes\/syc-20354022. Accessed 10 Apr 2024"},{"issue":"2","key":"8062_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/ncn3.143","volume":"3","author":"H Nodera","year":"2015","unstructured":"Nodera H, Takamatsu N, Muguruma N, Ukimoto K, Nishio S, Oda M et al (2015) Frequent hepatic steatosis in amyotrophic lateral sclerosis: Implication for systemic involvement. Neurol Clin Neurosci 3(2):58\u201362","journal-title":"Neurol Clin Neurosci"},{"issue":"1","key":"8062_CR22","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3(1):17071","journal-title":"Nat Rev Dis Primers"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08062-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08062-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08062-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:45:52Z","timestamp":1749530752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08062-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["8062"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08062-5","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval was required for this review article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial or non-financial interests"}},{"value":"The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}